{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:58:46Z","timestamp":1788317926563,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T00:00:00Z","timestamp":1452902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13550-016-0161-3","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T03:16:30Z","timestamp":1452914190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["177Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment"],"prefix":"10.1186","volume":"6","author":[{"given":"Ralf","family":"Bergmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Meckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojt\u011bch","family":"Kub\u00ed\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"R\u00f6sch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"key":"161_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2012.03.006","volume":"39","author":"O Sartor","year":"2013","unstructured":"Sartor O, Hoskin P, Bruland OS. Targeted radio-nuclide therapy of skeletal metastases. Cancer Treat Rev. 2013;39:18\u201326.","journal-title":"Cancer Treat Rev"},{"key":"161_CR2","first-page":"317","volume":"154","author":"J Kutzner","year":"1978","unstructured":"Kutzner J, Grimm W, Hahn K. Palliative radiotherapy with Strontium-89 in case of extended formation of skeleton metastases. Struct Bond (Berlin). 1978;154:317\u201322.","journal-title":"Struct Bond (Berlin)"},{"issue":"4","key":"161_CR3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10147-013-0597-7","volume":"19","author":"S Zenda","year":"2013","unstructured":"Zenda S, Nakagami Y, Toshima M, Arahira S, Kawashima M, Matsumoto Y, et al. Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases. Int J Clin Oncol. 2013;19(4):739\u201343.","journal-title":"Int J Clin Oncol"},{"issue":"J.G. Hamilton","key":"161_CR4","first-page":"171","volume":"12","author":"MH Williams","year":"1956","unstructured":"Williams MH, Hamilton JG, Johnston ME, Asing CW, Durbin PW. The metabolism of the lanthanons in the rat. II. Time studies of the tissue deposition of intravenously administered radioisotopes. USAEC Report. 1956;12(J.G. Hamilton):171.","journal-title":"USAEC Report"},{"key":"161_CR5","first-page":"49","volume":"10","author":"RE O\u2019Mara","year":"1968","unstructured":"O\u2019Mara RE, McAfee JG, Subramanian G. Rare earth nuclides as potential agents for skeletal imaging. J Nucl Med. 1968;10:49\u201351.","journal-title":"J Nucl Med"},{"key":"161_CR6","unstructured":"Lutetium-177: handling precautions, 2010, Perkin-Elmer Inc. www.perkinelmer.com."},{"issue":"8","key":"161_CR7","first-page":"1197","volume":"40","author":"P Tomassetti","year":"2013","unstructured":"Tomassetti P, Falconi M, Delle Fave G, Cacciari G, Tamburrino D, Pantuzo F, et al. Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. EJMMI. 2013;40(8):1197\u2013205.","journal-title":"EJMMI"},{"issue":"2","key":"161_CR8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RLU.0b013e318279bf4d","volume":"38","author":"J Yuan","year":"2013","unstructured":"Yuan J, Lui C, Liu X, Wang Y, Kuai D, Zhang G, et al. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study. Clin Nucl Med. 2013;38(2):88\u201392.","journal-title":"Clin Nucl Med"},{"key":"161_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00006231-200201000-00011","volume":"23","author":"S Chakraborty","year":"2002","unstructured":"Chakraborty S, Das T, Unni PR, Sarma HD, Samuel G, Banerjee S, et al. 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation. Nucl Med Comm. 2002;23:67\u201374.","journal-title":"Nucl Med Comm"},{"key":"161_CR10","doi-asserted-by":"crossref","unstructured":"F. K. Kalman, R. Kiraly, E. Br\u00fccher, Stability constants and dissociation rates of the EDTMP complexes of Samarium(III) and Yttrium(III), Eur J Inorg Chem; 2008;30:4719\u20134727","DOI":"10.1002\/ejic.200800582"},{"key":"161_CR11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0969-8051(97)80001-7","volume":"24","author":"BJ Beyer","year":"1997","unstructured":"Beyer BJ, Offord R, K\u00fcnzi G, Aleksandrova Y, Ravn U, Jahn S, et al. The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice. Nucl Med & Biol. 1997;24:367\u201372.","journal-title":"Nucl Med & Biol"},{"key":"161_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02347463","volume":"241","author":"J Byeg\u00e5rd","year":"1999","unstructured":"Byeg\u00e5rd J, Skarnemark G, Skalberg M. The stability of some metal EDTADTPA and DOTA complexes: application as tracers in groundwater studies. J Radioanal & Nucl Chem. 1999;241:281\u201390.","journal-title":"J Radioanal & Nucl Chem"},{"key":"161_CR13","doi-asserted-by":"crossref","first-page":"143202","DOI":"10.1088\/0953-8984\/23\/14\/143202","volume":"23","author":"L Smentek","year":"2011","unstructured":"Smentek L. Lanthanides caged by the organic chelates; structural properties. J Phys Condens Matter. 2011;23:143202.","journal-title":"J Phys Condens Matter"},{"key":"161_CR14","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.apradiso.2008.02.061","volume":"66","author":"S Chakrabotry","year":"2008","unstructured":"Chakrabotry S, Das T, Sarma HD, Venkatesh M, Banerjee S. Comparative studies of 177Lu\u2013EDTMP and 177Lu\u2013DOTMP as potential agents for palliative radiotherapy of bone metastasis. Appl Radiat Isot. 2008;66:1196\u2013205.","journal-title":"Appl Radiat Isot"},{"key":"161_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nucmedbio.2007.03.002","volume":"34","author":"K Kletter","year":"2007","unstructured":"Kletter K, Dudczak R, Kluger R, Viernstein H, Ettlinger DE, Eidherr H, et al. Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP. Nucl Med & Biol. 2007;34:391\u20137.","journal-title":"Nucl Med & Biol"},{"key":"161_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1524\/ract.2011.1791","volume":"99","author":"M Fellner","year":"2011","unstructured":"Fellner M, Riss P, Loktionova N, Zhernosekov K, Thews O, Geraldes CFGC, et al. Comparison of different phosphorus-containing ligands complexing 68Ga for PET-imaging of bone metabolism. Radiochim Acta. 2011;99:43\u201351.","journal-title":"Radiochim Acta"},{"key":"161_CR17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.nucmedbio.2012.04.007","volume":"39","author":"M Fellner","year":"2012","unstructured":"Fellner M, Biesalski B, Bausbacher N, Kubicek V, Hermann P, R\u00f6sch F, et al. 68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter. Nucl Med & Biol. 2012;39:993\u20139.","journal-title":"Nucl Med & Biol"},{"key":"161_CR18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/jm7012776","volume":"51","author":"T Vitha","year":"2008","unstructured":"Vitha T, Kubicek V, Hermann P, Elst LV, Mueller RN, Kolar ZI, et al. Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy. J Med Chem. 2008;51:677\u201383.","journal-title":"J Med Chem"},{"issue":"2","key":"161_CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone. 1996;18(2):75\u201385.","journal-title":"Bone"},{"key":"161_CR20","first-page":"834","volume":"37","author":"M Fellner","year":"2010","unstructured":"Fellner M, Baum RP, Kubicek V, Herrman P, Lukes I, Prasad V, et al. PET\/CT imaging of osteoblastic bone metastases with 68Ga-bisphosphonates: first human study. EJNMMI. 2010;37:834.","journal-title":"EJNMMI"},{"issue":"2","key":"161_CR21","first-page":"122","volume":"10","author":"J Holub","year":"2015","unstructured":"Holub J, Meckel M, Kubicek V, R\u00f6sch F, Hermann P. Gallium(III) complexes of NOTA-bis(phosphonate) conjugates as radiotracers for bone imaging. CMMI. 2015;10(2):122\u201334.","journal-title":"CMMI"},{"key":"161_CR22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.nucmedbio.2013.04.012","volume":"40","author":"M Meckel","year":"2013","unstructured":"Meckel M, Fellner M, Thieme N, Bergmann R, Kubicek V, R\u00f6sch F. In vivo comparison of DOTA based 68Ga-labelled bisphosphonates for bone imaging in non-tumour models. Nucl Med & Biol. 2013;40:823\u201330.","journal-title":"Nucl Med & Biol"},{"key":"161_CR23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.nucmedbio.2010.12.004","volume":"38","author":"K Ogawa","year":"2011","unstructured":"Ogawa K, Takai K, Kanbara H, Kiwada T, Kitamura Y, Shiba K, et al. Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent. Nucl Med & Biol. 2011;38:631\u20136.","journal-title":"Nucl Med & Biol"},{"key":"161_CR24","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1021\/la702753j","volume":"24","author":"T Vitha","year":"2008","unstructured":"Vitha T, Kubicek V, Hermann P, Kolar ZI, Wolterbeek HT, Peters JA, et al. Complexes of DOTA-bisphosphonate conjugates: probes for determination of adsorption capacity and affinity constants of hydroxyapatite. Langmuir. 2008;24:1952\u20138.","journal-title":"Langmuir"},{"key":"161_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0969-8043(99)00284-5","volume":"53","author":"F R\u00f6sch","year":"2000","unstructured":"R\u00f6sch F, Brockmann J, Misiak R, Novgorodov AF, Lebedev NA. Radiochemical separation of no-carrier-added 177Lu as produced via the 176Yb(n,\u03b3)177Yb\u00ae177Lu process. Appl Radiat Isot. 2000;53:421\u20135.","journal-title":"Appl Radiat Isot"},{"key":"161_CR26","first-page":"492","volume":"6","author":"PJ Riss","year":"2011","unstructured":"Riss PJ, Burchardt C, R\u00f6sch F. A methodical 68Ga\u2010labelling study of DO2A\u2010(butyl\u2010L\u2010tyrosine) 2 with cation\u2010exchanger post-processed 68Ga: practical aspects of radiolabelling. CMMI. 2011;6:492\u20138.","journal-title":"CMMI"},{"key":"161_CR27","doi-asserted-by":"crossref","first-page":"16477","DOI":"10.1021\/ja054905u","volume":"127","author":"V Kubicek","year":"2005","unstructured":"Kubicek V, Rudovsky J, Kotek J, Hermann P, Elst LV, Mueller RN, et al. A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting. J Am Chem Soc. 2005;127:16477\u201385.","journal-title":"J Am Chem Soc"},{"key":"161_CR28","first-page":"3204","volume":"17","author":"JA Peters","year":"2009","unstructured":"Peters JA, Lukes I, Mueller RN, Elst LV, Hermann P, Kotek J, et al. Gd(III) complex of a monophosphinate-bis(phosphonate) DOTA analogue with a high relaxivity; lanthanide(III) complexes for imaging and radiotherapy of calcified tissues. Dalton Trans. 2009;17:3204\u201314.","journal-title":"Dalton Trans"},{"key":"161_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/096032718400300602","volume":"3","author":"W Sontag","year":"1984","unstructured":"Sontag W. Long-term behavior of 239Pu, 241Am and 233U in different bones of one-year-old rats: macrodistribution and macrodosimetry. Human Toxicol. 1984;3:69\u2013483.","journal-title":"Human Toxicol"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-016-0161-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-016-0161-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-016-0161-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T16:07:53Z","timestamp":1553616473000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ejnmmires.com\/content\/6\/1\/5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1186\/s13550-016-0161-3","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,16]]},"article-number":"5"}}